sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Updated 10/6/2026, 8:26 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| LYEL Lyell Immunopharma, Inc. | Sale | $6,350 | Shook David Chief Medical Officer | 500 sh | at $12.70 | Filed Sep 10, 7:37 PM ET | Filing | |
| LYEL Lyell Immunopharma, Inc. | Sale | $149,013 | Seely Lynn President and CEO, Director | 9,589 sh | at $15.54 | Filed Aug 25, 4:06 PM ET | Filing | |
| LYEL Lyell Immunopharma, Inc. | Sale | $15,369 | Hill Stephen J. Chief Operating Officer | 989 sh | at $15.54 | Filed Aug 25, 4:05 PM ET | Filing | |
| LYEL Lyell Immunopharma, Inc. | Sale | $22,642 | Lee Gary K. Chief Scientific Officer | 1,457 sh | at $15.54 | Filed Aug 25, 4:03 PM ET | Filing | |
| LYEL Lyell Immunopharma, Inc. | Sale | $8,905 | Bulis Veronica Sanchez VP, Corporate Controller | 621 sh | at $14.34 | Filed Aug 11, 4:21 PM ET | Filing | |
| LYEL Lyell Immunopharma, Inc. | Sale | $1,879 | Lee Gary K. Chief Scientific Officer | 131 sh | at $14.34 | Filed Aug 11, 4:20 PM ET | Filing | |
| LYEL Lyell Immunopharma, Inc. | Sale | $1,276 | Hill Stephen J. Chief Operating Officer | 89 sh | at $14.34 | Filed Aug 11, 4:18 PM ET | Filing | |
| LYEL Lyell Immunopharma, Inc. | Sale | $5,593 | Seely Lynn President and CEO, Director | 390 sh | at $14.34 | Filed Aug 11, 4:07 PM ET | Filing | |
| LYEL Lyell Immunopharma, Inc. | Sale | $137 | Innovative Cellular Therapeutics Holdings Ltd 10% owner | 10 sh | at $13.70 | Filed Jul 20, 2:55 PM ET | Filing | |
| LYEL Lyell Immunopharma, Inc. | Sale | $137 | Innovative Cellular Therapeutics Holdings Ltd 10% owner | 10 sh | at $13.73 | Filed Jul 17, 9:45 PM ET | Filing |